News | 12.02.19
CryoLife Receives CE Mark for E-nya Thoracic Stent Graft
December 2, 2019—CryoLife, Inc. announced it has received European CE Mark approval for the E-nya thoracic stent graft system for the minimally invasive repair of lesions of the descending thoracic aorta, including thoracic aortic aneurysms and dissections.
News | 11.05.19
Endospan's Nexus Arch Branch Stent Graft System Studied at 2 Years
November 5, 2019—VIVA Physicians announced that 2-year results from a prospective, multicenter, premarket study composed of 25 patients (mean age, 73 years) treated with the Nexus aortic arch stent graft (Endospan) were presented by Daniel Clair, MD, in a late-breaking clinical trial session at VIVA 2019, the Vascular InterVentional Advances meeting held November 4–7 in Las Vegas, Nevada.
News | 10.31.19
Medtronic's Valiant Navion TEVAR Device Approved and Launched in Japan
October 31, 2019—Medtronic announced the launch of the Valiant Navion thoracic stent graft in Japan, where the Ministry of Health, Labour and Welfare granted it Shonin approval for the endovascular repair of thoracic descending aortic aneurysms and complicated type B aortic dissections (TBADs).
News | 09.26.19
Sex-Specific Differences Evaluated in Management of Descending TAA
September 26, 2019—In European Journal of Vascular and Endovascular Surgery (2019;58:503–511), Pinar Ulug, MD, et al published findings from a systematic review with meta-analysis to evaluate sex-specific differences in the management of descending thoracic aortic aneurysms (TAAs).
News | 04.17.19
Postmarket Data Support Cook's Zenith t-Branch Endograft to Treat TAAA
April 17, 2019—An off-the-shelf endograft (Zenith t-Branch, Cook Medical) for the treatment of thoracoabdominal aortic aneurysm (TAAA) provides a safe and straightforward solution for a wide range of patients—including emergency cases—according to findings presented by Martin Austermann, MD, at the Charing Cross Symposium, held April 15–18 in London, United Kingdom.
News | 01.30.19
Five-Year RESCUE Trial Data Evaluate Medtronic's Valiant Captivia Device in Blunt Thoracic Aortic Injury
January 30, 2019—Medtronic announced new data supporting the long-term durability, safety, and efficacy of its Valiant Captivia thoracic stent graft system for the treatment of blunt thoracic aortic injury (BTAI).
News | 11.13.18
Medtronic Receives CE Mark Approval for the Valiant Navion Thoracic Stent Graft System
November 13, 2018—Medtronic announced that it has received CE Mark approval for the Valiant Navion thoracic stent graft system for the endovascular repair of all lesions of the descending thoracic aorta, including thoracic aortic aneurysms (TAAs), blunt traumatic aortic injuries, penetrating atherosclerotic ulcers (PAUs), intramural hematomas, and type B aortic dissections.
News | 10.23.18
FDA Approves Medtronic's Valiant Navion Thoracic Stent Graft System
October 23, 2018—Medtronic announced that it has received FDA approval for its Valiant Navion thoracic stent graft system for thoracic endovascular aneurysm repair (TEVAR) of all lesions of the descending thoracic aorta, including thoracic aortic aneurysms (TAAs), blunt thoracic aortic injuries, penetrating atherosclerotic ulcers (PAUs), intramural hematomas, and type B aortic dissections.
News | 07.03.18
Gore's TAG Conformable Thoracic Stent Graft With Active Control System Introduced in Australia
July 2, 2018—Gore & Associates announced the commercial introduction in Australia of its TAG conformable thoracic stent graft with Active Control system, which was included on the Australian Register of Therapeutic Goods last month.
News | 05.16.18
Study Evaluates TEVAR for Chronic Type B Aortic Dissections
May 15, 2018—A study of the outcomes of thoracic endovascular aortic repair (TEVAR) for chronic type B aortic dissection (TBAD) was published by Allan M. Conway, MBChB, et al in the Journal of Vascular Surgery (2018;67:1345–1352). The investigators assessed the effectiveness of TEVAR in the treatment of chronic TBAD using the Vascular Quality Initiative (VQI) database.
News | 12.05.17
Enrollment Begins in Trial of Bolton Medical's RelayPro for Treatment of Blunt Traumatic Aortic Injury
December 5, 2017—Bolton Medical, Inc. announced that the first patient has been enrolled in the US Food and Drug Administration phase 2 clinical trial of the company's RelayPro in treating blunt traumatic aortic injury.
News | 11.02.17
European Postmarket Registry Begins for Gore's TAG Conformable Thoracic Stent Graft With Active Control System
November 2, 2017—Gore & Associates recently announced the first enrollment in its postmarket European SURPASS registry for its TAG conformable thoracic stent graft with Active Control system.
News | 10.03.17
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.